Digoxin-Specific Antibody Fragments: How Much and When?

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.23, Iss.3, 2004-01, pp. : 135-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How Much Is Too Much?

By COLEMAN WILLIAM P.

Dermatologic Surgery, Vol. 22, Iss. 11, 1996-11 ,pp. : 978-978

Elsevier

Access to resources Recommend Favorite

Digoxin: Arrhythmias, treated with anti-digoxin polyclonal antibody: case report

Reactions Weekly, Vol. 1, Iss. 1352, 2011-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?

By De Martin Eleonora Rodriguez-Castro Kryssia I Vitale Alessandro Zanus Giacomo Senzolo Marco Russo Francesco Paolo Burra Patrizia

Future Virology, Vol. 6, Iss. 10, 2011-10 ,pp. : 1179-1186

Future Medicine

Access to resources Recommend Favorite

Imatinib Dosing in Gastrointestinal Stromal Tumors (GISTs): When, How Much, and How Long?

Current Clinical Pharmacology, Vol. 10, Iss. 4, 2015-10 ,pp. : 311-320

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant antibody fragments as autoantibody antagonists

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 1, 2003-01 ,pp. : 129-133

Informa Healthcare

Access to resources Recommend Favorite